Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Newsdesk

402 Posts

Pfizer defends Covid-19 vaccine effectiveness after Trump remarks post image

Pfizer defends Covid-19 vaccine effectiveness after Trump remarks

Health Ministry to amend 2019 rules for new drugs, clinical trials post image

Health Ministry to amend 2019 rules for new drugs, clinical trials

Artelo Biosciences Announces Positive Interim Phase 2 CAReS Results for the Treatment of Cancer Anorexia-Cachexia Syndrome (CACS) post image

Artelo Biosciences Announces Positive Interim Phase 2 CAReS Results for the Treatment of Cancer Anorexia-Cachexia Syndrome (CACS)

FDC Ltd Elevates Field Force Efficiency with SANeForce SFA: A 6-Year Partnership Driving Productivity Across 11 Divisions post image

FDC Ltd Elevates Field Force Efficiency with SANeForce SFA: A 6-Year Partnership Driving Productivity Across 11 Divisions

60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference post image

60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference

Top Startup and Tech Funding News - September 2, 2025 post image

Top Startup and Tech Funding News - September 2, 2025

Global drugmakers rush to boost US presence as tariff threat looms post image

Global drugmakers rush to boost US presence as tariff threat looms

First Covid Pill That Prevents Infection After Exposure Awaits FDA Approval post image

First Covid Pill That Prevents Infection After Exposure Awaits FDA Approval

Pfizer defends COVID-19 vaccine after Trump criticism post image

Pfizer defends COVID-19 vaccine after Trump criticism

Drugmakers Boost U.S. Manufacturing Amid Tariff Threats post image

Drugmakers Boost U.S. Manufacturing Amid Tariff Threats

Artelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2 CAReS Results post image

Artelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2 CAReS Results

Gilead starts building manufacturing hub under $32 billion planned US investments post image

Gilead starts building manufacturing hub under $32 billion planned US investments